查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861619

手术缝合市场按产品类型、最终用户、应用、适应症和伤口类型划分 - 全球预测 2025-2032

Surgical Incision Closures Market by Product Type, End User, Application, Indication, Wound Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，手术缝合市场将成长至 288.5 亿美元，复合年增长率为 7.04%。

关键市场统计数据
基准年 2024 167.4亿美元
预计年份：2025年 179.4亿美元
预测年份 2032 288.5亿美元
复合年增长率 (%) 7.04%

本文简要概述了现代伤口缝合的临床、操作和商业性方面，重点介绍了各医疗保健相关人员的策略重点。

手术缝合仍然是手术全期护理的基础要素，它影响所有医疗机构的临床疗效、患者復健时间和手术效率。材料科学、器材工程和微创技术的进步改变了外科医生和护理团队选择缝合方案的方式，而不断变化的医保报销机制和医院采购重点也在持续影响着缝合方案的采用模式。因此，相关人员需要全面观点临床疗效、营运影响和采购实际情况，才能做出明智的选择。

材料技术、器械人体工学和门诊手术趋势的创新融合，正在重新定义临床对缝合解决方案的偏好和采购标准。

由于技术创新、外科手术技术的发展趋势以及政策的转变，手术缝合领域正在迅速变化。生物材料（例如可吸收止血基质和生物可吸收缝合线聚合物）的重大进步，显着改善了其操作性和性能，从而缩短了手术时间并创伤治疗。同样，电动缝合器和一次性输送系统的符合人体工学的改进，简化了器械在微创手术流程中的应用，并确保了不同经验水平的外科医生都能获得一致的手术效果。

评估关税主导的供应链调整和采购应对措施，以重塑闭合装置的采购、製造在地化和商业合约实务。

主要贸易伙伴修订关税政策的实施，为医疗设备製造商、经销商和医疗保健采购商带来了新的成本动态变化。关税措施影响了成品和关键原材料的到岸成本，迫使製造商重新评估其供应链布局和筹资策略。为此，一些供应商正在加快替代供应商的资格认证，将部分生产业务迁至更靠近终端市场的地方，或与通路合作伙伴重新协商商业条款，以维持利润率和竞争力。

详细的细分结构将产品类型、临床应用场景、临床适应症和伤口分类联繫起来，以驱动产品开发、证据生成和上市优先排序。

了解产品和终端用户细分对于将创新与临床需求和商业性机会相结合至关重要。产品细分包括止血剂、缝合钉、缝线和组织黏合剂。止血剂包括可吸收明胶海绵、氧化再生纤维素和凝血酶製剂，每种止血剂的操作特性和止血效果各不相同，这会影响外科专科的选择。缝合钉有手动和电动两种类型，由于其稳定性和速度优势，电动缝合钉越来越受到复杂和微创手术的青睐。缝合线分为可吸收缝合线和不可吸收缝合线。可吸收材料，例如Poliglecaprone、氧环己酮聚合体和聚乙醇酸，因其可预测的吸收特性和抗拉强度而被选用。同时，不可吸收材料，例如尼龙、聚丙烯和丝，仍适用于特定组织类型和需要长期抗拉强度的情况。组织黏合剂分为氰基丙烯酸酯黏合剂、纤维蛋白胶和聚乙二醇密封剂，每种黏合剂都适用于特定的伤口环境和临床路径。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势对比，导致了闭合技术的采用、监管策略和商业模式的差异。

区域趋势对技术采纳路径、报销环境和供应链结构有显着影响。在美洲，医疗保健系统采用公私混合采购模式，因此，能够缩短住院时间和提高手术效率的价值提案更容易被支付方和大型医院系统接受。手术自动化和门诊扩张方面的转型投资正在推动对支援当日出院通讯协定的易用型封闭系统的需求。

竞争动态和企业策略表明，产品创新、伙伴关係和供应链韧性如何在闭合装置市场创造独特的优势。

伤口缝合领域的竞争趋势反映了渐进式产品改进与颠覆性材料创新之间的平衡。现有医疗设备製造商持续投资于迭代改进，例如改良缝合线涂层、新一代止血基质和符合人体工学的缝合钉固定装置。同时，新兴参与企业则专注于新型黏合剂、生物活性密封剂和整合式输送系统，以减少手术室操作步骤。这种产品创新方向，在可靠的真实世界数据和针对性培训计画的支持下，影响着临床选择，并创造了差异化竞争的机会。

製造商和医疗保健提供者可以采取切实可行的策略步骤，以加强证据产生、实现采购多元化，并使定价与医疗保健总成本保持一致。

产业领导者应采取多管齐下的方法，整合临床证据、营运价值和供应链韧性。首先，应优先投资于针对特定专科终点和使用者体验变数的临床试验和真实世界证据。这将有助于降低产品推广门槛，同时加强处方集申报和临床医生的认可。同时，应开发满足不同场所（例如门诊中心、医院手术室、诊所和居家医疗机构）独特需求的产品组合和差异化SKU，以简化采购和使用决策。

一个透明的混合方法研究框架，结合临床访谈、二手证据综合和检验，旨在为闭合装置产生可靠的策略性见解。

本分析综合了结构化混合方法研究途径结合了初步访谈、文献综述和严格的三角验证，以确保研究结果的可靠性和相关性。初步研究包括与各专科的临床负责人、医院系统和门诊中心的供应链主管以及提供营运背景的监管和报销专家进行深入讨论。文献综述则利用同侪审查的临床文献、监管文件和公共政策文件来检验技术主张并分析其应用趋势。

总之，这项综合分析强调了临床证据、程序人体工学和供应链适应性之间的相互作用，以决定长期实施的成功。

外科性创伤缝合技术涉及临床疗效、手术效率和供应链复杂性三个面向。生物材料和器械设计的创新正在改善外科医生的操作体验和患者预后，但商业性成功取决于能否将这些进步与切合实际的采购优先事项和稳健的生产策略相结合。整合可靠的临床证据、灵活的采购策略和临床医生参与的相关人员，将更有能力最大限度地发挥新型缝合技术的价值。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大抗菌缝合线涂层的应用，以降低术后感染率
  • 将智慧伤口监测装置整合到缝合线中，以获取即时癒合数据
  • 在微创手术中，对能够实现无结扎组织缝合的倒刺缝合线的需求日益增长。
  • 透过开发基于可生物降解聚合物的闭合技术，改善患者的创伤治疗效果。
  • 拓展机器人缝合技术，以提高复杂手术的精准度

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按产品类型手术缝合市场

  • 止血材料
    • 吸水明胶海绵
    • 氧化再生纤维素
    • 基于凝血酶
  • 史泰博
    • 手动输入
    • 电的
  • 缝合线
    • 吸收性
      • Poliglecaprone
      • 氧环己酮聚合体
      • 聚乙醇酸
    • 不可吸收
      • 尼龙
      • 聚丙烯
      • 丝绸
  • 组织黏合剂
    • 氰基丙烯酸黏合剂
    • 纤维蛋白胶
    • 聚乙二醇密封剂

第九章 按最终使用者分類的手术缝合市场

  • 门诊手术中心
  • 诊所
    • 多专科医疗机构
    • 单一专科
  • 居家医疗
  • 医院
    • 私人的
    • 民众

第十章手术缝合市场：依应用领域划分

  • 外部的
  • 内部的

第十一章 依适应症分類的手术缝合市场

  • 心血管系统
  • 一般外科
  • 妇科
  • 神经外科
  • 整形外科
  • 儿童外科

第十二章 按伤口类型分類的手术缝合市场

  • 清洁伤口
  • 半清洁伤口
  • 受污染的伤口
  • 化脓性伤口

第十三章手术缝合市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章手术缝合市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国手术缝合市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • 3M Company
    • B. Braun Melsungen AG
    • Smith & Nephew plc
    • Baxter International Inc.
    • Teleflex Incorporated
    • Integra LifeSciences Holdings Corporation
    • Coloplast A/S
    • Terumo Corporation
Product Code: MRR-69324464D312

The Surgical Incision Closures Market is projected to grow by USD 28.85 billion at a CAGR of 7.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.74 billion
Estimated Year [2025] USD 17.94 billion
Forecast Year [2032] USD 28.85 billion
CAGR (%) 7.04%

A concise orientation to the clinical, operational, and commercial dimensions of modern incision closure that frames strategic priorities for varied healthcare stakeholders

Surgical incision closure remains a foundational element of perioperative care, affecting clinical outcomes, patient recovery times, and procedural efficiency across care settings. Advances in materials science, device engineering, and minimally invasive techniques have changed how surgeons and care teams select closure solutions, while evolving reimbursement frameworks and hospital procurement priorities continue to shape adoption patterns. As a result, stakeholders require an integrated view that combines clinical performance, operational impact, and procurement realities to make informed choices.

This executive summary synthesizes the latest evidence and strategic considerations relevant to clinicians, supply chain leaders, and investors. It emphasizes the interplay between product innovation and system-level pressures, addressing how closure technologies contribute to infection prevention, hemostasis control, and suture line integrity in diverse surgical populations. Moreover, it highlights the importance of aligning device selection with workflow constraints in ambulatory surgical centers, hospitals, clinics, and home care environments, where device ease of use and compatibility with existing protocols drive purchasing decisions.

Moving from clinical to commercial perspectives, the introduction frames the competitive dynamics among hemostats, staples, sutures, and tissue adhesives, and it underscores the regulatory and quality assurance pressures that influence product development cycles. The goal is to present a balanced, actionable orientation that prepares readers to interpret subsequent sections on market shifts, tariff implications, segmentation insights, and recommended strategic responses.

How converging innovations in materials, device ergonomics, and outpatient procedural trends are redefining clinical preferences and procurement criteria in closure solutions

The landscape for surgical incision closure has undergone rapid transformation driven by technology, procedural trends, and policy shifts. Key advances in biomaterials, such as absorbable hemostatic matrices and bioresorbable suture polymers, now offer improved handling and performance characteristics that reduce procedure time and enhance wound healing. Similarly, ergonomic improvements in powered stapling and single-use delivery systems have simplified device integration into minimally invasive workflows, thereby enabling more consistent outcomes across surgeon experience levels.

Concurrently, clinical pathways are shifting toward outpatient and ambulatory care, which increases demand for closure solutions that prioritize rapid application, robust hemostasis, and minimal follow-up. This trend has encouraged manufacturers to design products that combine clinical efficacy with operational simplicity, ensuring that devices meet both clinical and throughput objectives. In parallel, regulatory scrutiny and an emphasis on real-world evidence have elevated the need for robust post-market surveillance and comparative clinical data, prompting suppliers to invest in registries and prospective studies.

Taken together, these shifts are reshaping procurement criteria: value is now measured not only by unit price but also by total cost of care impacts, including infection reduction, readmission avoidance, and OR efficiency gains. As a result, successful market entrants demonstrate differentiated clinical benefits, seamless integration into clinical workflows, and credible evidence packages that resonate with both clinicians and hospital administrators.

Assessment of tariff-driven supply chain adjustments and procurement responses that are reshaping sourcing, manufacturing localization, and commercial contracting practices for closure devices

The introduction of revised tariff policies by major trade partners has introduced new cost dynamics that affect device manufacturers, distributors, and healthcare purchasers. Tariff actions influence the landed cost of both finished goods and critical raw materials, creating pressure on manufacturers to reassess supply chain footprints and sourcing strategies. In response, some suppliers have accelerated efforts to qualify alternate suppliers, relocated certain manufacturing steps closer to end markets, or restructured commercial terms with channel partners to preserve margin and competitiveness.

From a hospital and clinic perspective, procurement teams are increasingly focused on cost transparency and contract flexibility. Transitional measures, such as inventory hedging and negotiated price escalators tied to input cost indices, have become more common. At the same time, clinicians remain sensitive to device performance and safety implications of material substitutions, which requires careful validation and communication from suppliers. Consequently, manufacturers that combine supply chain resilience with demonstrable clinical continuity achieve stronger commercial outcomes.

Importantly, tariff pressures have also accelerated conversations around nearshoring and the diversification of supplier bases. This strategic pivot reduces exposure to single-country risks but introduces complexity in regulatory conformity and quality assurance. Therefore, companies with robust global quality systems and adaptable manufacturing processes are better positioned to manage tariff-driven disruptions while maintaining product innovation and clinical support.

In-depth segmentation architecture linking product modalities, care settings, clinical indications, and wound classifications to inform product development, evidence generation, and go-to-market prioritization

Understanding product and end-user segmentation is essential to aligning innovation with clinical need and commercial opportunity. Product divisions encompass hemostats, staples, sutures, and tissue adhesives, where hemostats include absorbable gelatin sponges, oxidized regenerated cellulose, and thrombin-based formulations, each offering distinct handling characteristics and hemostatic profiles that influence selection by surgical specialty. Staples are offered in manual and powered variants, with powered systems increasingly favored in complex and minimally invasive procedures for their consistency and speed. Sutures divide into absorbable and non-absorbable categories; absorbable materials such as poliglecaprone, polydioxanone, and polyglycolic acid are chosen for their predictable resorption and tensile properties, while non-absorbable options like nylon, polypropylene, and silk remain relevant for specific tissue types and long-term tensile requirements. Tissue adhesives span cyanoacrylate adhesives, fibrin sealants, and polyethylene glycol-based sealants, each suited to particular wound environments and clinical adoption pathways.

End-user segmentation differentiates care settings that impose distinct operational constraints and purchasing behaviors. Ambulatory surgical centers emphasize rapid turnover and cost containment, clinics-both multi-specialty and single-specialty-prioritize ease of use and inventory simplicity, home care demands low-burden application and safety for non-clinical caregivers, and hospitals-public and private-balance clinical efficacy with procurement cycles and contract performance criteria. Applications are classified as external or internal, with internal applications often requiring higher regulatory scrutiny and supporting evidence due to implantation and absorptive behavior.

Clinical indications and wound types further refine product fit: cardiovascular, general surgery, gynecology, neurosurgery, orthopedic, and pediatric indications each present unique tissue handling and hemostasis needs, while wound classifications such as clean, clean contaminated, contaminated, and dirty shape infection control expectations and device selection. Integrating these segmentation layers enables suppliers to prioritize R&D, tailor messaging to procurement stakeholders, and design clinical studies that address specialty-specific endpoints and real-world usability considerations.

Comparative regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive differentiated adoption, regulatory strategies, and commercial models for closure technologies

Regional dynamics exert a strong influence on technology adoption paths, reimbursement environments, and supply chain configurations. In the Americas, healthcare systems present a mix of private and public procurement models, where value propositions that demonstrate reduced length of stay and improved procedural throughput often resonate with payers and large hospital systems. Transitional investments in surgical automation and outpatient expansion drive demand for user-friendly closure systems that support same-day discharge protocols.

In Europe, the Middle East & Africa, regulatory harmonization efforts and varying reimbursement models create a mosaic of adoption criteria. Centralized procurement in some European markets favors standardized product portfolios, while emerging markets within the region prioritize affordability and ease of training. Meanwhile, the Middle East and Africa exhibit pockets of rapid adoption for advanced technologies in tertiary centers, balanced by significant variability in supply chain maturity and access to specialized training.

Asia-Pacific demonstrates heterogeneity across mature markets with high rates of minimally invasive surgery and rapidly growing surgical volumes in developing economies. Manufacturers succeed in this region when they combine localized clinical education programs with adaptable pricing strategies and supply chain flexibility. Across regions, stakeholders that can localize regulatory submissions, invest in clinician training, and adapt commercial models to payer structures gain competitive advantage.

Competitive dynamics and corporate strategies demonstrating how product innovation, partnerships, and supply chain resilience create distinct advantages in closure device markets

Competitive dynamics in the incision closure space reflect a balance between incremental product refinement and disruptive material innovation. Established device manufacturers continue to invest in iterative improvements-such as enhanced suture coatings, next-generation hemostatic matrices, and ergonomic stapling mechanisms-while emerging entrants focus on novel adhesives, bioactive sealants, and integrated delivery systems that reduce steps in the operating room. These product innovation trajectories affect clinical preference and create differentiation opportunities when supported by robust real-world data and targeted training programs.

Strategic collaborations and selective acquisitions have become important pathways for companies to expand their clinical portfolios and accelerate time to market. Partnerships with academic centers and surgical networks enable faster evidence generation and early clinician advocacy, which in turn influence hospital formulary decisions. Moreover, companies that invest in digital support tools-such as procedural guidance platforms and post-market outcome tracking-strengthen customer relationships by demonstrating commitment to long-term clinical performance.

Supply chain resilience, regulatory compliance, and the ability to navigate tariff environments also distinguish leading companies. Firms that maintain diversified manufacturing footprints, transparent quality systems, and agile commercial strategies are better positioned to respond to procurement pressures and clinician expectations. Ultimately, competitive advantage accrues to organizations that align material science innovation with pragmatic clinical support and clear evidence of procedural benefit.

Practical and implementable strategic steps for manufacturers and healthcare providers to strengthen evidence generation, diversify sourcing, and align pricing with total cost of care imperatives

Industry leaders should adopt a multi-faceted approach that aligns clinical evidence, operational value, and supply chain resilience. First, prioritize investment in targeted clinical studies and real-world evidence that address specialty-specific endpoints and user experience variables; this will strengthen formulary submissions and clinician advocacy while reducing adoption friction. In parallel, develop product bundles or differentiated SKUs that match the unique needs of ambulatory centers, hospital ORs, clinics, and home care environments to simplify procurement and usage decisions.

Second, implement supply chain diversification strategies to mitigate tariff and geopolitical exposure. This includes qualifying alternate material suppliers, exploring regional manufacturing partnerships, and refining logistics agreements to ensure consistent product availability. Third, enhance commercial engagement through clinician education programs and digital tools that support procedural adoption and outcomes tracking, thereby building long-term relationships grounded in demonstrable clinical value.

Finally, align pricing and contracting strategies with total cost of care arguments, emphasizing reductions in infection rates, readmissions, and OR time. By presenting clear models that translate clinical performance into operational savings, manufacturers can secure preferred positioning during competitive procurement cycles. These combined actions will help organizations navigate current market pressures while creating durable pathways for growth.

Transparent mixed-method research framework combining clinical interviews, secondary evidence synthesis, and triangulated validation to produce reliable strategic insights for closure devices

This analysis synthesizes insights drawn from a structured, mixed-method research approach combining primary interviews, secondary literature review, and rigorous triangulation to ensure credibility and relevance. Primary research included in-depth discussions with clinical leaders across a range of specialties, supply chain executives from hospital systems and ambulatory centers, and regulatory and reimbursement experts who provided operational context. Secondary analysis drew on peer-reviewed clinical literature, regulatory filings, and publicly available policy documents to validate technical claims and to map adoption trends.

Data synthesis employed cross-validation methods to reconcile differing viewpoints and reduce bias. Clinical inputs were weighted against documented outcomes and device performance data, while procurement and supply chain observations were calibrated with documented policy changes and trade developments. Quality controls included expert peer review and methodological audits to ensure that conclusions rest on confirmed evidence and transparent assumptions. Limitations are acknowledged where gaps in public data exist, and recommendations emphasize adaptive strategies that can be refined as new evidence emerges.

Concluding synthesis emphasizing the critical interplay of clinical evidence, procedural ergonomics, and supply chain adaptability that determines long-term adoption success

Surgical incision closure sits at the intersection of clinical performance, procedural efficiency, and supply chain complexity. Innovations in biomaterials and device design are improving surgeon experience and patient outcomes, yet commercial success depends on aligning those advancements with pragmatic procurement priorities and resilient manufacturing strategies. Stakeholders who integrate robust clinical evidence with adaptive sourcing and clinician engagement will be best positioned to capture the value generated by new closure technologies.

As regulatory scrutiny intensifies and healthcare delivery models continue to evolve toward outpatient care, the ability to demonstrate real-world benefits and operational impact becomes critical. Companies that invest in targeted clinical programs, localized commercialization efforts, and diversified supply chains will reduce adoption friction and preserve margin integrity. Conversely, those that rely solely on unit cost competition without substantiating clinical value may face increasing procurement headwinds.

In conclusion, a disciplined focus on evidence, ergonomics, and supply chain adaptability offers the most reliable route to sustained adoption and commercial differentiation in the evolving world of surgical incision closure.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of antimicrobial suture coatings to reduce postoperative infection rates
  • 5.2. Integration of smart wound monitoring devices with suture lines for real-time healing data
  • 5.3. Growth in demand for barbed sutures enabling knotless tissue approximation in minimally invasive surgeries
  • 5.4. Advancements in biodegradable polymer-based closures for improved patient wound healing outcomes
  • 5.5. Expansion of robotic-assisted suture placement techniques increasing precision in complex procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Incision Closures Market, by Product Type

  • 8.1. Hemostats
    • 8.1.1. Absorbable Gelatin Sponges
    • 8.1.2. Oxidized Regenerated Cellulose
    • 8.1.3. Thrombin Based
  • 8.2. Staples
    • 8.2.1. Manual
    • 8.2.2. Powered
  • 8.3. Sutures
    • 8.3.1. Absorbable
      • 8.3.1.1. Poliglecaprone
      • 8.3.1.2. Polydioxanone
      • 8.3.1.3. Polyglycolic Acid
    • 8.3.2. Non Absorbable
      • 8.3.2.1. Nylon
      • 8.3.2.2. Polypropylene
      • 8.3.2.3. Silk
  • 8.4. Tissue Adhesives
    • 8.4.1. Cyanoacrylate Adhesives
    • 8.4.2. Fibrin Sealants
    • 8.4.3. Polyethylene Glycol Sealants

9. Surgical Incision Closures Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
    • 9.2.1. Multi Specialty
    • 9.2.2. Single Specialty
  • 9.3. Home Care
  • 9.4. Hospitals
    • 9.4.1. Private
    • 9.4.2. Public

10. Surgical Incision Closures Market, by Application

  • 10.1. External
  • 10.2. Internal

11. Surgical Incision Closures Market, by Indication

  • 11.1. Cardiovascular
  • 11.2. General Surgery
  • 11.3. Gynecology
  • 11.4. Neurosurgery
  • 11.5. Orthopedic
  • 11.6. Pediatric

12. Surgical Incision Closures Market, by Wound Type

  • 12.1. Clean
  • 12.2. Clean Contaminated
  • 12.3. Contaminated
  • 12.4. Dirty

13. Surgical Incision Closures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Incision Closures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Incision Closures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Johnson & Johnson
    • 16.3.2. Medtronic plc
    • 16.3.3. 3M Company
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Smith & Nephew plc
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Teleflex Incorporated
    • 16.3.8. Integra LifeSciences Holdings Corporation
    • 16.3.9. Coloplast A/S
    • 16.3.10. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SURGICAL INCISION CLOSURES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SURGICAL INCISION CLOSURES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL INCISION CLOSURES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY